Pharmaron Beijing Co., Ltd. (Stock Code: 3759) has scheduled its first extraordinary general meeting of 2025 on December 18, 2025, at 2:30 p.m. in Beijing, the People’s Republic of China. Shareholders on record as of December 15, 2025, are entitled to attend and vote.
Key matters on the agenda include a by-election of an independent non-executive director and proposed amendments to multiple corporate policies, such as those governing related party transactions, external guarantees, the working procedures of independent non-executive directors, the management of proceeds, and the implementation of the cumulative voting mechanism. Additional special resolutions focus on amending the Articles of Association and the rules of procedure for general and board meetings.
The register of H share members will be closed from December 15 through December 18, 2025. Shareholders planning to attend should complete the necessary transfers and proxy submissions in accordance with the relevant regulations and deadlines set forth in the notice.
Comments